Literature DB >> 6114818

Adhesion of enterotoxigenic Escherichia coli in humans and animals.

M M Levine.   

Abstract

Enterotoxigenic Escherichia coli (ETEC), an important cause of diarrhoea in humans and animal, require accessory virulence properties in addition to enterotoxin to manifest virulence. Several classes of pili (hair-like protein surface organelles) promote adhesion of ETEC to small intestinal mucosa. Antibody directed against adhesion pili interferes with colonization of the small intestine and prevents disease. This paper reviews studies with purified K88, K99 and 987 type pili used as parenteral vaccines in pregnant pigs and cattle. Infant animals suckled on immunized mothers were significantly protected against fatal disease. Colonization factor antigen (CFA) I and II pili, and type 1 somatic pili, promote adhesion of human ETEC pathogens to epithelial cells in vitro and are generally recognized as accessory virulence factors. CFA/I and II were found in only 25% of 36 human ETEC infections; positive strains were usually LT+/ST+ (LT: heat-labile; ST: heat-stable). Strains lacking CFA/I and II are virulent; other factors must be responsible for adhesion in such strains. While none of 14 LT+/ST- strains elaborated CFA/I or II, 10 (71%) possessed type 1 somatic pili. An initial ETEC diarrhoeal infection in volunteers stimulated protective immunity against diarrhoea on re-challenge with the same strain. Despite clinical protection healthy "veterans" excreted the ETEC strain to the same degree as ill controls. Thus the mechanisms of immunity was not bactericidal. Disease-induced LT antitoxic immunity failed to protect volunteers against challenge with a heterologous (LT+/ST-) strain. One explanation of these observations is that the mechanism of protection was anti-adhesive with antibody directed against adhesive factors on the bacterial surface preventing attachment of bacteria to receptors on small intestinal mucosal cells. Immunoprophylaxis against ETEC in humans with purified pili vaccines appears feasible.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6114818     DOI: 10.1002/9780470720639.ch10

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  10 in total

1.  Ultrastructural study of adhesion of enterotoxigenic Escherichia coli to erythrocytes and human intestinal epithelial cells.

Authors:  S Knutton; D R Lloyd; D C Candy; A S McNeish
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

2.  Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans.

Authors:  M M Levine; P Ristaino; G Marley; C Smyth; S Knutton; E Boedeker; R Black; C Young; M L Clements; C Cheney
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

Review 3.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

4.  Adherence and penetration of vascular endothelium by Candida yeasts.

Authors:  S A Klotz; D J Drutz; J L Harrison; M Huppert
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

Review 5.  Novel antigens for enterotoxigenic Escherichia coli vaccines.

Authors:  James Fleckenstein; Alaullah Sheikh; Firdausi Qadri
Journal:  Expert Rev Vaccines       Date:  2014-04-04       Impact factor: 5.217

6.  Oligomannoside-type glycopeptides inhibiting adhesion of Escherichia coli strains mediated by type 1 pili: preparation of potent inhibitors from plant glycoproteins.

Authors:  J R Neeser; B Koellreutter; P Wuersch
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

7.  Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells.

Authors:  Galliano Zanello; Mustapha Berri; Joëlle Dupont; Pierre-Yves Sizaret; Romain D'Inca; Henri Salmon; François Meurens
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

8.  Highly conserved type 1 pili promote enterotoxigenic E. coli pathogen-host interactions.

Authors:  Alaullah Sheikh; Rasheduzzaman Rashu; Yasmin Ara Begum; F Matthew Kuhlman; Matthew A Ciorba; Scott J Hultgren; Firdausi Qadri; James M Fleckenstein
Journal:  PLoS Negl Trop Dis       Date:  2017-05-22

9.  The role of CFA/I in adherence and toxin delivery by ETEC expressing multiple colonization factors in the human enteroid model.

Authors:  Emily M Smith; Christen L Grassel; Antonia Papadimas; Jennifer Foulke-Abel; Eileen M Barry
Journal:  PLoS Negl Trop Dis       Date:  2022-07-26

10.  Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.

Authors:  Fernando Güereña-Burgueño; Eric R Hall; David N Taylor; Frederick J Cassels; Daniel A Scott; Marcia K Wolf; Zachary J Roberts; Galina V Nesterova; Carl R Alving; Gregory M Glenn
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.